Imagine taking an ordinary cell from your skin and asking it a question that would once have sounded completely impossible:
Could this cell become the beginning of a new human life?
For most of human history, the answer would have been an obvious no. A skin cell is a skin cell. A sperm cell is a sperm cell. An egg is an egg.
But modern biology is beginning to challenge the boundaries between these different cellular identities.
One of the most intriguing developments is a technique called mitomeiosis. The name combines two familiar biological processes: mitosis, the ordinary division of body cells, and meiosis, the special division that produces eggs and sperm.
The idea is not yet a way to make babies from skin cells. It is much more experimental than that.
But it may represent an important step toward something much bigger: in-vitro gametogenesis, or IVG, the possibility of creating reproductive cells from ordinary body cells.
And if that technology continues to develop, the consequences could eventually go far beyond medicine.
They could change how we think about reproduction, parenthood, identity, and even what it means to be biologically male or female.
First, what is mitosis?
To understand mitomeiosis, we first need to understand what happens inside an ordinary human cell.
Most cells in our body contain 46 chromosomes. These chromosomes contain our DNA, the genetic instructions that help determine how our bodies develop and function.
When an ordinary body cell divides, it usually does so through a process called mitosis.
The cell copies its genetic material and produces two daughter cells with essentially the same chromosome number.
In simple terms:
46 → 46 + 46
This is extremely useful.
Our bodies constantly need new cells. We need new skin cells, blood cells and many other kinds of cells throughout our lives. But reproduction has a different problem. If an egg contained 46 chromosomes and a sperm contained 46 chromosomes, fertilization would produce a cell with 92 chromosomes. That is not how normal human reproduction works. This is where meiosis becomes important.
What makes meiosis different?
Eggs and sperm are produced through a special type of cell division called meiosis.
Instead of maintaining 46 chromosomes, meiosis reduces the chromosome number by half.
So:
46 → 23
An egg normally contains 23 chromosomes, while a sperm contains another 23.
When they meet:
The embryo therefore receives the normal human chromosome number.
But meiosis is much more complicated than simply cutting 46 chromosomes in half.
During natural meiosis, chromosomes pair with their corresponding partners. They can exchange pieces of DNA in a process called crossing-over. They are then carefully separated so that the resulting reproductive cells receive an appropriate set of chromosomes.
This process also creates genetic diversity.
Nature has spent millions of years refining this machinery.
And this is precisely why creating an egg from an ordinary body cell is such a difficult problem.
Where does mitomeiosis come in?
Imagine taking the nucleus of a human skin cell.
Inside that nucleus are normally 46 chromosomes.
Researchers have explored ways of placing such a nucleus inside a human egg cell from which the original nucleus has been removed. This general approach is known as somatic cell nuclear transfer, or SCNT.
But there is an obvious problem.
The skin-cell nucleus still contains 46 chromosomes.
If it is eventually used in a reproductive process involving sperm containing 23 chromosomes, the chromosome numbers would not be correct. Researchers therefore need a way to reduce the chromosome number. This is where the experimental idea of mitomeiosis enters the picture.
The basic concept is to push the chromosomes from a body-cell nucleus into a division that reduces their number before fertilization. It resembles part of what happens during meiosis, but it does not reproduce natural meiosis perfectly. That distinction is extremely important.
Mitomeiosis is not ordinary meiosis.
It is an experimental approach to chromosome reduction.
Is mitomeiosis really artificial meiosis?
Not exactly. Natural meiosis contains highly organized biological steps. Homologous chromosomes pair with one another. DNA can be exchanged through crossing-over. The chromosomes are then separated through carefully controlled mechanisms. In the experimental mitomeiosis approach, the chromosomes do not reproduce all of these natural steps.
Instead, chromosome separation can be much more random. That creates a serious problem. Imagine that you have a puzzle containing 23 pieces. You might say:
“There are 23 pieces, so the puzzle must be correct.”
But what if one important piece is missing and another piece appears twice? The number is correct. The puzzle is not. The same principle applies to chromosomes. It is not enough to produce a cell containing approximately 23 chromosomes. The cell needs the right 23 chromosomes, arranged correctly.
A cell could potentially receive two copies of one chromosome and none of another. Such abnormalities can make normal embryonic development impossible. This is one of the major scientific challenges facing mitomeiosis.
What happened in 2025?
In 2025, researchers reported an experimental technique using a human egg-cell environment to reduce the chromosome number of a somatic, or body-cell, genome. The work was described as a proof of concept, rather than a practical fertility treatment. The researchers were able to produce reconstructed egg-like cells in which the chromosome number had been reduced. Some of the fertilized cells were also able to begin early embryonic development.
On average, the resulting cells could retain around 23 chromosomes from the original somatic genome. That was remarkable. But it was not enough. Chromosomal abnormalities remained a major problem, and the efficiency was low.
This is why headlines suggesting that scientists can simply “make human eggs from skin cells” need to be treated carefully. The experiment demonstrated an important biological principle. It did not produce a reliable supply of healthy human eggs suitable for fertility treatment. The difference between those two statements is enormous.
A laboratory experiment that allows an embryo-like structure to begin developing is very different from a technology capable of safely producing a healthy human baby.
Could this eventually help people have biological children?
Potentially.
This is where mitomeiosis becomes part of the much larger field of in-vitro gametogenesis, or IVG. The long-term idea is fascinating:
ordinary body cell → reproductive cell → fertilization → embryo
Instead of requiring a naturally produced egg or sperm, scientists could potentially begin with an ordinary cell from the body. For someone who has few or no usable reproductive cells, such technology could one day offer a completely new route to biological parenthood.
But mitomeiosis solves only one part of the puzzle. A reproductive cell is not defined simply by having 23 chromosomes.
There are also complex processes involving epigenetics, genetic imprinting, mitochondria, cellular development and the surrounding cytoplasm.
A skin cell is not simply an unfinished egg.
It has been programmed to behave as a skin cell.
Turning it into a functional reproductive cell means changing far more than its chromosome number.
Would a child created this way be a clone?
Not necessarily.
This is another important distinction.
If a person’s body cell were used to create a reproductive cell, much of the resulting genetic material could come from that person. But if that reproductive cell were fertilized by sperm from another person, the resulting embryo would contain genetic material from both sources. It would therefore not simply be an exact genetic copy of the original person.
Mitochondrial DNA could also introduce another genetic contribution because mitochondria are located in the egg-cell cytoplasm. So IVG is not simply another name for cloning. It is potentially something quite different.
The possibility of one person becoming both genetic father and mother
This is where the subject becomes even more extraordinary. A man normally has one X chromosome and one Y chromosome. A typical female cell has two X chromosomes. For a male-derived cell to become an egg-like cell, scientists would therefore have to overcome this fundamental genetic difference.
Experiments in mice have already demonstrated remarkable steps in this direction. Researchers have created eggs from cells derived from male mice and used them in experiments involving sperm from another male.
Other experiments have even attempted to produce mice with two genetic fathers and no genetic mother, although these experiments involved major biological difficulties and extremely limited survival. The human situation is far more complicated.
But imagine a future in which scientists could take a man’s ordinary body cell and produce from it both:
a sperm cell and an egg cell.
That would create a strange new biological possibility. A single man could, in genetic terms, potentially provide both sides of the reproductive contribution. He would not simply be “father and mother” in the social or biological sense, those concepts are much more complicated than genetics alone. But he could potentially become the genetic source of both reproductive cells. And this is where science begins to enter philosophy.
2030-2035: Learning to control the chromosomes
If the technology continues developing, the next major challenge would be precision. educing chromosome numbers is one thing. Controlling which chromosomes are retained is another.
Between 2030 and 2035, a plausible development would be increasingly sophisticated methods for identifying chromosomal abnormalities. Advanced imaging, molecular signals and computer-assisted analysis could potentially help scientists recognize defective cells before they continue developing. The objective would no longer simply be:
“Did we get 23 chromosomes?”
It would become:
“Did we get the correct 23 chromosomes?”
That is a much harder question.
2035-2040: Reprogramming the cell
Even if chromosome segregation could be controlled perfectly, another enormous problem would remain. A skin cell has a completely different epigenetic state from an egg cell. Epigenetics refers, in simple terms, to molecular instructions that influence which genes are active and which are silent. A future technology would therefore need to reset much of the cell’s biological programming.
The goal would be something like:
body cell → genome reset → germ-cell development
The cell would have to stop behaving like a skin cell and acquire the complex characteristics of a reproductive cell.
2040-2045: Functional human gametes?
If these technologies developed successfully, the period between 2040 and 2045 could potentially see experimental attempts to create increasingly functional human reproductive cells from adult somatic cells. This would represent a major conceptual change. A skin cell would no longer be viewed simply as a skin cell. It would become a kind of biological starting material.
One cell could potentially be transformed into another cellular identity. And that raises a profound question:
How many different biological futures are hidden inside one ordinary cell?
2050-2051: From mitomeiosis to controlled reproduction
By 2050–2051, in this hypothetical future scenario, mitomeiosis might no longer be regarded as an isolated technique. It could become one part of a much larger reproductive system:
somatic cell → genome reset → germ-cell development → chromosome reduction → mature gamete → embryo
The original problem of reducing 46 chromosomes to 23 might eventually look almost simple compared with everything else. The real challenge would be controlling the entire process. And this is where the technology could become philosophically extraordinary.
Imagine giving a laboratory a single skin cell. That cell contains the person’s complete diploid genome. With sufficiently advanced IVG technology, it might become possible to produce multiple reproductive cells from that original biological material. Then the question changes.
It is no longer simply: “Can we make a gamete?”
It becomes: “Which gamete do we choose?”
The new ethical problem
Once scientists can create reproductive cells from ordinary body cells, another possibility appears. What if many different gametes could be produced from the same person? What if embryos could then be created and genetically analysed before implantation? The technological question would gradually transform into a question of selection.
Instead of asking: Can we create a child? society might eventually have to ask: Which possible child do we choose?
This is where the greatest controversy may ultimately lie. Not in mitomeiosis itself. But in the choices that could become possible because of it. The technology could potentially help people who cannot otherwise have genetically related children. It could change possibilities for infertility.
It could potentially offer new reproductive options to people whose biological circumstances currently prevent them from producing eggs or sperm. But the same technology could also challenge our ideas about genetic selection, disability, equality, parenthood and human identity.
What happens to the meaning of “mother” and “father”?
This may be one of the deepest questions raised by IVG. For thousands of years, human reproduction has been connected to a basic biological division: egg + sperm.
The people providing those cells have traditionally been understood through concepts such as mother and father. But what happens if an egg can be produced from a person’s ordinary body cell? What happens if sperm can also be produced from body cells? And what happens if both reproductive cells can ultimately originate from the same person?
The old categories may no longer describe every biological possibility. That does not mean that the words mother and father become meaningless. It means that biology could become more complicated than the categories we inherited from it.
From “Can we?” to “Who decides?”
Perhaps the most interesting part of mitomeiosis is therefore not the technology itself. It is the question that follows it. In 2025, the question was essentially:
Can a body-cell genome be reduced to a haploid state inside an egg-cell environment?
That is already a remarkable scientific question. But imagine the technological progression continuing through 2030, 2035, 2040, 2045 and eventually 2051. The question could gradually become: Can an ordinary human cell be transformed into a functional reproductive cell?
And after that: Can we control exactly which genetic combination it produces?
And eventually: Who decides what that cell becomes?
That may be the real philosophical heart of mitomeiosis. A skin cell is normally just a skin cell. But if science learns how to change its biological destiny, the boundary between what a cell is and what a cell can become begins to disappear. The technology would then no longer be only about chromosomes.
It would be about identity, reproduction and choice.
In 2025, the question was: “Can we make an egg from a cell?” by 2051, the deeper question may be: “If we can, who decides what that cell becomes?”
And perhaps that is the moment when mitomeiosis stops being merely a biological experiment and becomes a question about the future of humanity itself.